NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,670 Cr | ₹1,684 Cr | ₹1,524 Cr | ₹1,669 Cr | ₹1,543 Cr |
What is the latest Revenue of NECTAR LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,670 Cr |
| Mar2024 | ₹1,684 Cr |
| Mar2023 | ₹1,524 Cr |
| Mar2022 | ₹1,669 Cr |
| Mar2021 | ₹1,543 Cr |
How is Revenue of NECTAR LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,670 Cr | -0.84 | |
| Mar2024 | ₹1,684 Cr | 10.53 | |
| Mar2023 | ₹1,524 Cr | -8.70 | |
| Mar2022 | ₹1,669 Cr | 8.13 | |
| Mar2021 | ₹1,543 Cr | - | |
Compare Revenue of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹409.3 Cr | -4.4% | -13.3% | -52.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -4.4% |
-13.3% |
-52.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses